I'd like an explanation for the negative revenues for Q4. "It sure is nice to see those checks come in"... HA. It appears they sold nothing, and, even worse, had to re-classify something for the auditors to give us a reduction from the April 10Q.
We need/deserve some sort of communication on current Q sales estimates. (Since I'm sure they are not allowed to speak to the Q1 that just closed)
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links